Genital warts

M Steben, SM Garland - Best practice & research Clinical obstetrics & …, 2014 - Elsevier
Anogenital warts (AGWs) are a very common disease. They are caused mostly by low-risk
human papillomaviruses (HPV) 6 and 11, particularly the former. Clinical presentation is …

Genital warts and cost of care in England

S Desai, S Wetten, SC Woodhall, L Peters… - Sexually transmitted …, 2011 - sti.bmj.com
Objectives To estimate the total number of cases of, and cost of care for, genital warts (GWs)
in England, to inform economic evaluations of human papillomavirus vaccination. Methods …

[HTML][HTML] Incidence of anogenital warts in Germany: a population-based cohort study

AA Kraut, T Schink, R Schulze-Rath… - BMC infectious …, 2010 - Springer
Background Human papilloma virus (HPV) types 6 and 11 account for 90 percent of
anogenital warts (AGW). Assessment of a potential reduction of the incidence of AGW …

[HTML][HTML] Clinical effectiveness and cost-effectiveness of interventions for the treatment of anogenital warts: systematic review and economic evaluation.

E Thurgar, S Barton, C Karner… - Health Technology …, 2016 - ncbi.nlm.nih.gov
BACKGROUND Typically occurring on the external genitalia, anogenital warts (AGWs) are
benign epithelial skin lesions caused by human papillomavirus infection. AGWs are usually …

[HTML][HTML] Towards the eradication of HPV infection through universal specific vaccination

P Crosignani, A De Stefani, GM Fara, AM Isidori… - BMC public health, 2013 - Springer
Abstract Background The Human Papillomavirus (HPV) is generally recognized to be the
direct cause of cervical cancer. The development of effective anti-HPV vaccines, included in …

[HTML][HTML] Measuring school level attributable risk to support school-based HPV vaccination programs

C Vujovich-Dunn, H Wand, JML Brotherton, H Gidding… - BMC public health, 2022 - Springer
Abstract Background In Australia in 2017, 89% of 15-year-old females and 86% of 15-year-
old males had received at least one dose of the HPV vaccine. However, considerable …

[HTML][HTML] Cost and effectiveness evaluation of prophylactic HPV vaccine in developing countries

W Termrungruanglert, P Havanond, N Khemapech… - Value in Health, 2012 - Elsevier
Background Approximately 80% of cervical cancer cases occur in developing countries. In
Thailand, cervical cancer has been the leading cancer in females, with an incidence of 24.7 …

Population-wide vaccination against human papillomavirus in adolescent boys: Australia as a case study

M Georgousakis, S Jayasinghe, J Brotherton… - The Lancet infectious …, 2012 - thelancet.com
Female-only vaccination programmes for human papillomavirus (HPV) have been
introduced in many countries aimed at the prevention of cervical cancer in women. One HPV …

Near elimination of genital warts in Australia predicted with extension of human papillomavirus vaccination to males

IA Korostil, H Ali, RJ Guy, B Donovan… - Sexually transmitted …, 2013 - journals.lww.com
Background The National Human Papillomavirus (HPV) Vaccination Program for females
delivering the quadrivalent vaccine Gardasil has been included in the National …

[HTML][HTML] Decreased management of genital warts in young women in Australian general practice post introduction of national HPV vaccination program: results from a …

C Harrison, H Britt, S Garland, L Conway, A Stein… - PLoS …, 2014 - journals.plos.org
Objectives Since the introduction of Australia's human papillomavirus vaccination program,
the management rate of genital warts in sexual health clinics and private hospitals has …